| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 34 |
| 1 | LAMIVUDINE ORAL | 33 |
| 2 | ENTECAVIR | 30 |
| 3 | ENTECAVIR ANHYDROUS | 30 |
| 4 | ZIDOVUDINE | 4 |
| 5 | SOFOSBUVIR | 3 |
| 6 | ADEFOVIR DIPIVOXIL | 1 |
| 7 | AMLODIPINE | 1 |
| 8 | BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE | 1 |
| 9 | COLCHICINE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ENTECAVIR | 30 | 0.0025 |
| 1 | LAMIVUDINE | 34 | 0.0013 |
| 2 | ADEFOVIR DIPIVOXIL | 1 | 0.0008 |
| 3 | ZIDOVUDINE | 4 | 0.0004 |
| 4 | SOFOSBUVIR | 3 | 0.0002 |
| 5 | RILPIVIRINE | 1 | 0.0001 |
| 6 | NEVIRAPINE | 1 | 0.0001 |
| 7 | LOPINAVIR AND RITONAVIR | 1 | 0.0001 |
| 8 | RITONAVIR 100 MG | 1 | 0.0001 |
| 9 | LEDIPASVIR AND SOFOSBUVIR | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 39 | 0.0008 |
| 1 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 36 | 0.0003 |
| 2 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 4 | 0.0001 |
| 3 | Protease Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Alkaloid [EPC] | 1 | 0.0000 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Nucleoside Analog Antiviral [EPC] | 1 | 0.0000 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 1 | 0.0000 |